Travel Injections Ltd Filleted Accounts Cover
Travel Injections Ltd
Company No. 10726704
Information for Filing with The Registrar
30 April 2025
Travel Injections Ltd Directors Report Registrar
The Directors present their report and the accounts for the year ended 30 April 2025.
Principal activities
The Company is dormant and has not traded during the year.
Directors
The Directors who served at any time during the year were as follows:
J.N. Issac
P.S. Sagoo
P.S. Saundh
S.S. Sihra
The above report has been prepared in accordance with the provisions applicable to companies subject to the small companies regime as set out in Part 15 of the Companies Act 2006.
Signed on behalf of the board
S.S. Sihra
Director
04 January 2026
Travel Injections Ltd Balance Sheet Registrar
at
30 April 2025
Company No.
10726704
Notes
2025
2024
£
£
Fixed assets
Tangible assets
5
--
Creditors: Amount falling due within one year
6
(75,137)
(75,137)
Net current liabilities
(75,137)
(75,137)
Total assets less current liabilities
(75,137)
(75,137)
Net liabilities
(75,137)
(75,137)
Capital and reserves
Called up share capital
100100
Profit and loss account
8
(75,237)
(75,237)
Total equity
(75,137)
(75,137)
For the year ending 30 April 2025 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
These accounts have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account.
Approved by the board on 04 January 2026 and signed on its behalf by:
S.S. Sihra
Director
04 January 2026
Travel Injections Ltd Notes to the Accounts Registrar
for the year ended 30 April 2025
1
General information
Travel Injections Ltd is a private company limited by shares and incorporated in England and Wales.
Its registered number is: 10726704
Its registered office is:
Imperial House
1a Standen Avenue
Hornchurch
Essex
RM12 6AA
The accounts have been prepared in accordance and comply with FRS 102 and Section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
2
Accounting policies
Revenue recognition
The company was dormant throughout the year and accordingly no turnover or other operating income arose in the period.
Tangible fixed assets and depreciation
Tangible fixed assets held for the company's own use are stated at cost less accumulated depreciation and accumulated impairment losses.

At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss.
Depreciation is provided at the following annual rates in order to write off the cost or valuation less the estimated residual value of each asset over its estimated useful life:
Plant and machinery
33% Straight line
Leased assets
The company had no leases in place during the year and accordingly no right‑of‑use assets or lease liabilities have been recognised in these financial statements in accordance with FRS 102 Section 20.
Trade and other creditors
Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.
3
Employees
2025
2024
Number
Number
The average monthly number of employees (including directors) during the year was:
44
4
Taxation
(a) Tax on profit on ordinary activities
2025
The tax charge is made up as follows:
£
UK corporation tax
(b) Factors affecting the total tax charge for the period
Profit on ordinary activities before tax
-
(1,176)
Standard rate of corporation tax in the United Kingdom
19%
19%
Profit on ordinary activities multiplied by standard rate of corporation tax in the United Kingdom
-
(223)
Expenses not deductible for tax purposes
-223
5
Tangible fixed assets
Plant and machinery
Total
£
£
Cost or revaluation
At 1 May 2024
38,82038,820
At 30 April 2025
38,82038,820
Depreciation
At 1 May 2024
38,82038,820
At 30 April 2025
38,82038,820
Net book values
At 30 April 2025
--
At 30 April 2024
-
-
6
Creditors:
amounts falling due within one year
2025
2024
£
£
Other creditors
75,13775,137
75,13775,137
7
Share Capital
100 x £1 Ordinary Shares called up and fully paid
8
Reserves
Profit and loss account - includes all current and prior period retained profits and losses.
Travel Injections Ltd1072670430 April 202501 May 2024true04 January 2026BTCSoftware AP Solution 2025 12.2.0212.2.02true107267042024-05-012025-04-30107267042025-04-30107267042024-04-3010726704core:WithinOneYear2025-04-3010726704core:WithinOneYear2024-04-3010726704core:ShareCapital2025-04-3010726704core:ShareCapital2024-04-3010726704core:RetainedEarningsAccumulatedLosses2025-04-3010726704core:RetainedEarningsAccumulatedLosses2024-04-3010726704countries:UnitedKingdom2024-05-012025-04-3010726704bus:RegisteredOffice2024-05-012025-04-3010726704core:PlantMachinery2024-05-012025-04-30107267042023-05-012024-04-3010726704core:PlantMachinery2024-05-01107267042024-05-0110726704core:PlantMachinery2025-04-3010726704core:RetainedEarningsAccumulatedLosses2024-05-012025-04-3010726704bus:EntityNoLongerTradingButTradedInPast2024-05-012025-04-3010726704bus:SmallEntities2024-05-012025-04-3010726704bus:FullAccounts2024-05-012025-04-3010726704bus:AuditExempt-NoAccountantsReport2024-05-012025-04-3010726704bus:Director42024-05-012025-04-3010726704bus:PrivateLimitedCompanyLtd2024-05-012025-04-30iso4217:GBPxbrli:pure